Targeting ion channels: innovative approaches to combat cancer drug resistance

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Ion channels regulate ion flow across cell membranes and are crucial for cell functions.
• Dysregulation of ion channels is a hallmark of cancer, contributing to cell survival and therapeutic resistance.
• Specific ion channels (sodium, potassium, calcium) and ions (ferrous) are linked to chemotherapy sensitivity and resistance.

Purpose of the Study:

• To review the current understanding of ion channel interactions with anticancer drug efficacy.
• To discuss the therapeutic potential of ion channel modulators in overcoming cancer drug resistance.
• To highlight ion channel targeting as a novel strategy in cancer therapy.

Main Methods:

• Literature review of preclinical and clinical studies.
• Analysis of evidence linking ion channel expression and function to cancer drug response.
• Synthesis of findings on ion channel blockers and modulators in cancer treatment.

Main Results:

• Aberrant expression of sodium (Na+) and potassium (K+) channels correlates with chemotherapy sensitivity.
• Calcium (Ca2+) channels contribute to resistance against targeted therapies like osimertinib in EGFR-mutant lung cancer.
• Ferrous ions (Fe2+) can enhance breast cancer cell sensitivity to doxorubicin.

Conclusions:

• Ion channels are critical regulators of cancer cell behavior and drug response.
• Modulating ion channel activity presents a viable strategy to improve anticancer drug efficacy.
• Targeting ion channels offers a promising avenue for overcoming therapeutic resistance in cancer treatment.